Earlier this year, Credit Suisse published a report blaming a focus on maximizing short-term profits and enabling "voracious risk-taking" by Archegos for failing to steer the bank away from catastrophe.
The slimmed down investment bank will focus on advising companies on deals and listings, and trading cash equities and other products that are of interest to its private banking clients. It will cut back its emerging market lending, structured derivatives and other "non-core" market businesses as well as prime broking.
Despite long-running discussions about Archegos - by far the bank's largest hedge fund client - Credit Suisse's top management were apparently unaware of the risks it was taking. The bank's chief risk officer and the head of its investment bank recall hearing about it first only on the eve of the fund's collapse.
Credit Suisse's financial humiliation stands in stark contrast to its cross-town rival UBS.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)